$87.90
Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 1
● 24
▼ 0
DexCom (DXCM) Stock Looks Undervalued On Fair Value While Earnings Look Fair
Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services
Overview
52-week range
$54
$93
88% of range
Avg surprise (last 2)
+1.8%
Avg reaction (last 1)
-1.6%
0% positive
Latest IV / EM
51%
EM ±2.1% · $90 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.64 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $0.51 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.70 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $0.48 | $0.45 | +6.7% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $0.32 | $0.33 | -3.0% | — | -1.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.34 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.35 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.36 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.29 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.28 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.12 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | — | $1.21B | $1.16B | $1.04B | — | $994M |
| Cost of revenue | $478M | $442M | — | $478M | $468M | $447M | — | $400M |
| Gross profit | $830M | $750M | — | $731M | $689M | $589M | — | $594M |
| Operating income | $318M | $255M | — | $242M | $213M | $134M | — | $152M |
| Net income | $249M | $200M | — | $284M | $180M | $105M | — | $135M |
| EPS (diluted) | $0.64 | $0.51 | — | $0.70 | $0.45 | $0.27 | — | $0.34 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M |
| Total current assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B |
| Total assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B |
| Total equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B |